EARNINGS PER SHARE - Schedule of Basic and Diluted Earnings (Loss) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended				6 Months Ended
	Jun. 26, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Numerator:
Net income		$ 53,043	$ 44,791	$ 114,403	$ 39,208	$ 97,834	$ 153,611
Denominator:
Weighted average number of common shares outstanding (in shares)		172,927		179,807		173,428	180,531
Effect of dilutive securities (in shares)		1,163		1,434		1,403	1,400
Weighted average number of common shares outstanding, diluted (in shares)		174,090		181,241		174,831	181,931
Earnings per common share, basic
Earnings per common share, basic (in dollars per share)		$ 0.31		$ 0.64		$ 0.56	$ 0.85
Earnings per common share, diluted
Earnings per common share, diluted (in dollars per share)		$ 0.30		$ 0.63		$ 0.56	$ 0.84
Amedisys
Earnings per common share, diluted
Termination fee	$ 106,000			$ 62,800			$ 62,800